WCN26-6976 INCREASE IN METFORMIN–ASSOCIATED LACTIC ACIDOSIS IN A TERTIARY CROATIAN HOSPITAL AFTER THE COVID PANDEMIC

Read full text Summarise with VIRAT
Authors: Karmela Altabas, Vesna Vucelić, Petar Gezman, Vesna Degoricija, Čolić Mia, Velimir Altabas
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Metformin has been a cornerstone of type 2 diabetes therapy for decades. It is inexpensive, widely available, and carries a low risk of hypoglycemia or weight gain. Its affordability, tolerability, and cardiovascular safety sustain its central role in modern diabetes management. Although generally well tolerated, its most serious adverse effect is metformin-associated lactic acidosis (MALA)—a rare but life-threatening condition, with an estimated incidence of 1 per 30,000 patient-years. MALA typically occurs in the presence of renal or hepatic impairment, sepsis, or dehydration.

Fields of Study & Subjects

Diabetes Treatment and Management Diabetes Management and Research COVID-19 Clinical Research Studies

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104567–104567
Publication date
25 March 2026
Language
EN